Business Context and Reporting Period
This Form 8-K Current Report was filed by Bristol-Myers Squibb Company on September 14, 2018. The report discloses a corporate governance event regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific corporate event and does not contain financial performance data.
Material Changes
- Board Resignation: On September 14, 2018, José Baselga, M.D., Ph.D., resigned from the Board of Directors.
- Board Size Reduction: Effective September 14, 2018, the size of the Board of Directors was decreased to eleven members in connection with Dr. Baselga's resignation.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the disclosed departure of a director.
Key Facts for Investor Verification
- Confirm the effective date of Dr. Baselga's resignation (September 14, 2018).
- Verify the new total size of the Board of Directors (eleven members).
- Check for any subsequent filings regarding the appointment of a replacement director.